A year after Abcuro raised $200 million to fund a phase 2/3 muscle disease trial of its anti-KLRG1 antibody, the study has ...

Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate ...

SHANNON, CLARE, IRELAND, February 5, 2026 /EINPresswire.com/ -- A new publication from Opto-Electronic Technology; DOI ...

Scientists at Microsoft Research in the United States have demonstrated a system called Silica for writing and reading ...

Council Approves Rezoning After Public Hearing, Addresses Parking and Park Concerns Residential development continues to push ...

As Singapore elevates its space ambitions, observers say the move is timely but comes with challenges, from crafting space ...

RISC-V’s expanding role in AI is not a rejection of incumbent architectures, which continue to deliver performance and ...

Q4 2025 Earnings Call February 23, 2026 4:45 PM ESTCompany ParticipantsRhonda Bennetto - Senior Vice President of ...

Eisai remains deeply committed to a patient-centered approach in Alzheimer's care and ensuring LEQEMBI (R) is available to those eligible and living with early AD in Canada. We will continue to pursue ...

At CES, MPS highlighted how its motor-control ICs can enable smarter, more precise control of brushless DC motors that are multiplying across robotics and other industries.

The MSI MEG X870E Ace is a feature-packed, high-end option. While it's expensive, it's hundreds of dollars cheaper than halo-tier boards.